In vitro activity of BAY 12-8039, a new fluoroquinolone.
The in vitro activity of BAY 12-8039, a new fluoroquinolone, was studied in comparison with those of ciprofloxacin, trovafloxacin (CP 99,219), cefpodoxime, and amoxicillin-clavulanate against gram-negative, gram-positive, and anaerobic bacteria. Its activity against mycobacteria and chlamydia was al...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1997
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163668/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8980763/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.1.101 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|